Pipeline for Uncoilable or Failed Aneurysms



Status:Completed
Conditions:Cardiology, Neurology
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology
Healthy:No
Age Range:21 - 75
Updated:11/22/2018
Start Date:October 2008
End Date:September 22, 2014

Use our guide to learn which trials are right for you!

To determine the safety and effectiveness of Pipeline Embolization Device for the treatment
of uncoilable or failed wide-necked intracranial aneurysms (IA).

Patients with large or giant aneurysms of the internal carotid artery treated with PED.
Angiographic follow-up occurs at 3 and 5 years.

Inclusion Criteria:

- Age 21 to 75 years, inclusive

- Patient has a single target IA in the anterior or posterior circulation that:

a) Is located in the following regions of the internal carotid artery: i.
Paraophthalmic (including paraclinoid, ophthalmic and hypophyseal segments) ii.
Cavernous iii. Petrous

b) Has a neck >4 mm or no discernible neck AND a size (maximum fundus diameter) >10 mm

c) Has a parent vessel with diameter 2.5 - 5.0 mm distal/proximal to the target IA

- Subject has provided written informed consent using the Institutional Review Board
(IRB)-approved consent form

- Subject has the necessary mental capacity to participate and is willing and able to
comply with protocol requirements

Exclusion Criteria:

- More than one IA requires treatment in the next 6 months

- Subarachnoid hemorrhage from target IA in the past 60 days

- Unstable neurologic deficit (i.e., any worsening of clinical condition in the last 30
days)

- Irreversible bleeding disorder

- Platelet count < 100 x 103 cells/mm3 or known platelet dysfunction

- Inability to tolerate, documented evidence of adverse reaction or contraindication to
study medications

- Stent in place at the target IA

- Contraindication to CT scan or MRI

- Allergy to contrast used in angiography that cannot be medically controlled

- Known severe allergy to platinum or cobalt/chromium alloys

- Relative contraindication to angiography (e.g., serum creatinine > 2.5 mg/dL)

- Woman of child-bearing potential who cannot provide a negative pregnancy test

- Evidence of active infection at the time of treatment

- Other conditions of the heart, blood, brain or intracranial vessels that carry a high
risk of neurologic events (e.g., severe heart failure, atrial fibrillation, known
carotid stenosis)

- Any comorbid disease or condition expected to compromise survival or ability to
complete follow-up assessments to 180 days

- Extracranial stenosis greater than 50% in the carotid artery for anterior circulation
aneurysms

- Intracranial stenosis greater than 50% in the treated vessel
We found this trial at
9
sites
70 Washington Square S
New York, New York 10012
(212) 998-1212
New York University More than 175 years ago, Albert Gallatin, the distinguished statesman who served...
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Budapest,
Click here to add this to my saved trials
Buffalo, New York 14215
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Phoenix, Arizona 85013
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Stony Brook, New York 11794
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
25 Winfield Road
Winfield, Illinois 60190
?
mi
from
Winfield, IL
Click here to add this to my saved trials